Celldex Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $29.3M | $98.0M | $11.9M |
| FY2012 | $29.8M | $125.5M | $24.9M |
| FY2013 | $27.3M | $347.1M | $169.4M |
| FY2014 | $36.4M | $248.0M | $28.0M |
| FY2015 | $47.5M | $337.6M | $72.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $29.3M | $98.0M | $11.9M |
| FY2012 | $29.8M | $125.5M | $24.9M |
| FY2013 | $27.3M | $347.1M | $169.4M |
| FY2014 | $36.4M | $248.0M | $28.0M |
| FY2015 | $47.5M | $337.6M | $72.1M |